Mirus Bio is a long-standing leader in the field of gene delivery technology. In addition to offering world-class transfection and electroporation products for basic research, we now focus on providing solutions for therapeutic viral vector production, protein production and CRISPR genome editing. Our most recent breakthrough product line of TransIT-VirusGEN® Transfection Regents provide superior titers for small-to-large scale production of AAV and lentiviral vectors, supporting gene therapy researchers from discovery to the clinic.